Related Experiment Video

Updated: Jun 13, 2026

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

Akt signaling pathway: a target for radiosensitizing human malignant glioma

Emmanuel Chautard1, Gaëlle Loubeau, Andreï Tchirkov

  • 1Centre Jean Perrin, Laboratoire de Radio-Oncologie Expérimentale, EA 3846 Thérapie Ciblée Combinatoire en Onco-Hématologie, Université d'Auvergne, Clermont-Ferrand, France. emmanuel.chautard@cjp.fr

Neuro-Oncology
|April 22, 2010
PubMed

Insights

Targeting the Akt pathway, not STAT3, enhances radiation sensitivity in glioblastoma. Inhibiting Akt signaling improves radiosensitization, offering a potential therapeutic strategy for this aggressive brain tumor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Glioblastoma treatment relies on radiation therapy, but tumor radioresistance limits its efficacy.
  • Phosphatidyl-inositol 3-kinase/protein kinase B (Akt) and Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways promote cell survival under radiation stress by inhibiting apoptosis.

Purpose of the Study:

  • To investigate the correlation between intrinsic radioresistance and basal activation of Akt and STAT3 pathways in human malignant glioma cell lines.
  • To evaluate the impact of modulating Akt or STAT3 signaling on glioma cell radiosensitivity in vitro.

Main Methods:

  • Screening of 8 human malignant glioma cell lines.
  • Assessment of basal Akt and STAT3 activation.
  • Clonogenic cell survival assays to determine surviving fraction at 2 Gy (SF2).
  • Inhibition of Akt using Akt inhibitor IV.
  • Inhibition of STAT3 using JSI-124 and a neutralizing gp130 antibody.

Main Results:

  • A significant correlation was observed between basal Akt activation and the surviving fraction at 2 Gy (SF2) in glioma cells.
  • No correlation was found between STAT3 activation and SF2.
  • Down-modulation of Akt significantly enhanced radiation sensitivity in glioma cells.
  • Down-modulation of STAT3 did not radiosensitize glioma cells.

Conclusions:

  • The Akt pathway is significantly correlated with intrinsic radioresistance in malignant glioma.
  • Targeting the Akt pathway, but not STAT3, with specific inhibitors can radiosensitize human malignant glioma cells.
  • The Akt pathway represents a more promising therapeutic target for enhancing glioblastoma radiosensitization compared to STAT3.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...